RESUMEN
The ESX-1 locus is a region critical for full virulence in Mycobacterium tuberculosis, which encodes two secreted proteins as well as other genes involved in their secretion. The mechanism of secretion of the two proteins, ESAT-6 and CFP-10, and their function remain unknown. Using proteomic methods to search for additional proteins secreted by the ESX-1 locus, we discovered that a protein encoded by a chromosomally unlinked gene, espA, is also secreted by strains that contain the ESX-1 locus but not by strains with ESX-1 deletions. Mutations in individual ESX-1 genes, including those that encode ESAT-6 and CFP-10, were found to block EspA secretion. Surprisingly, mutants that lack espA reciprocally failed to secrete ESAT-6 and CFP-10 and were as attenuated as ESX-1 mutants in virulence assays. The results indicate that secretion of these proteins, which are each critical for virulence of pathogenic mycobacteria, is mutually dependent. The results further suggest that discerning the nature of the interaction and the structure of macromolecular complexes will provide insights into both an alternative mechanism of protein secretion and mycobacterial virulence.
Asunto(s)
Antígenos Bacterianos/metabolismo , Proteínas Bacterianas/metabolismo , Complejos Multiproteicos/metabolismo , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/patogenicidad , Tuberculosis/inmunología , Animales , Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Secuencia de Bases , Western Blotting , Vectores Genéticos/genética , Espectrometría de Masas , Ratones , Ratones SCID , Datos de Secuencia Molecular , Complejos Multiproteicos/genética , Proteómica , VirulenciaAsunto(s)
Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Candida albicans/inmunología , Células Cultivadas , Escherichia coli/inmunología , Genómica , Humanos , Inmunidad Innata , Virus de la Influenza A/inmunología , Ligandos , Lipopolisacáridos/inmunología , Mananos/inmunología , Análisis de Secuencia por Matrices de Oligonucleótidos , ARN Bicatenario/inmunologíaRESUMEN
One overall challenge for public health and medicine in the future is to allocate available resources effectively to reduce major causes of disease burden globally and to decrease health disparities between poor and affluent populations. The major risk factors for death and disability worldwide are malnutrition; poor water supply, sanitation, and personal and domestic hygiene; unsafe sexual behavior; tobacco use; alcohol use; occupational hazards; hypertension; physical inactivity; illicit drugs; and air pollution. The challenge for research in the 21st century is to maintain and improve life expectancy and the quality of life that was achieved for most of the world's population during the 20th century.
Asunto(s)
Costo de Enfermedad , Investigación/tendencias , Salud Global , Humanos , Esperanza de Vida , Salud Pública , Calidad de VidaRESUMEN
Given the scope of the worldwide health problems caused by the acquired immunodeficiency syndrome, tuberculosis, and malaria, it is imperative that vaccines be developed to prevent these infections. Recent advances in the understanding of these diseases suggest that T-lymphocyte-mediated immunity is important in containing these infections. The application of novel vaccine technologies for eliciting this type of immunity promises to provide successful vaccines for controlling the spread of these deadly infections.
Asunto(s)
Vacunas contra el SIDA , Vacuna BCG , Vacunas contra la Malaria , Investigación/tendencias , Síndrome de Inmunodeficiencia Adquirida/prevención & control , Animales , Costo de Enfermedad , Predicción , Humanos , Malaria/prevención & control , Tuberculosis/prevención & controlRESUMEN
The mammalian innate immune system retains from Drosophila a family of homologous Toll-like receptors (TLRs) that mediate responses to microbial ligands. Here, we show that TLR2 activation leads to killing of intracellular Mycobacterium tuberculosis in both mouse and human macrophages, through distinct mechanisms. In mouse macrophages, bacterial lipoprotein activation of TLR2 leads to a nitric oxide-dependent killing of intracellular tubercle bacilli, but in human monocytes and alveolar macrophages, this pathway was nitric oxide-independent. Thus, mammalian TLRs respond (as Drosophila Toll receptors do) to microbial ligands and also have the ability to activate antimicrobial effector pathways at the site of infection.
Asunto(s)
Proteínas de Drosophila , Lipoproteínas/inmunología , Macrófagos/microbiología , Glicoproteínas de Membrana/metabolismo , Monocitos/microbiología , Mycobacterium tuberculosis/inmunología , Óxido Nítrico/metabolismo , Receptores de Superficie Celular/metabolismo , Animales , Proteínas Bacterianas/inmunología , Línea Celular , Células Cultivadas , Humanos , Interferón gamma/inmunología , Interferón gamma/farmacología , Ligandos , Activación de Macrófagos , Macrófagos/inmunología , Macrófagos/metabolismo , Macrófagos Alveolares/inmunología , Macrófagos Alveolares/metabolismo , Macrófagos Alveolares/microbiología , Macrófagos Peritoneales/inmunología , Macrófagos Peritoneales/metabolismo , Macrófagos Peritoneales/microbiología , Ratones , Monocitos/inmunología , Monocitos/metabolismo , Mycobacterium tuberculosis/crecimiento & desarrollo , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II , Transducción de Señal , Receptor Toll-Like 2 , Receptores Toll-Like , Factor de Necrosis Tumoral alfa/inmunología , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
Granulysin, a protein located in the acidic granules of human NK cells and cytotoxic T cells, has antimicrobial activity against a broad spectrum of microbial pathogens. A predicted model generated from the nuclear magnetic resonance structure of a related protein, NK lysin, suggested that granulysin contains a four alpha helical bundle motif, with the alpha helices enriched for positively charged amino acids, including arginine and lysine residues. Denaturation of the polypeptide reduced the alpha helical content from 49 to 18% resulted in complete inhibition of antimicrobial activity. Chemical modification of the arginine, but not the lysine, residues also blocked the antimicrobial activity and interfered with the ability of granulysin to adhere to Escherichia coli and Mycobacterium tuberculosis. Granulysin increased the permeability of bacterial membranes, as judged by its ability to allow access of cytosolic ss-galactosidase to its impermeant substrate. By electron microscopy, granulysin triggered fluid accumulation in the periplasm of M. tuberculosis, consistent with osmotic perturbation. These data suggest that the ability of granulysin to kill microbial pathogens is dependent on direct interaction with the microbial cell wall and/or membrane, leading to increased permeability and lysis.
Asunto(s)
Antibacterianos/toxicidad , Antígenos de Diferenciación de Linfocitos T/toxicidad , Permeabilidad de la Membrana Celular/inmunología , Escherichia coli/crecimiento & desarrollo , Mycobacterium tuberculosis/crecimiento & desarrollo , Subgrupos de Linfocitos T/inmunología , Secuencia de Aminoácidos , Antibacterianos/síntesis química , Antígenos de Diferenciación de Linfocitos T/biosíntesis , Antígenos de Diferenciación de Linfocitos T/genética , Permeabilidad de la Membrana Celular/efectos de los fármacos , Escherichia coli/efectos de los fármacos , Humanos , Concentración de Iones de Hidrógeno , Microscopía Electrónica , Datos de Secuencia Molecular , Mycobacterium tuberculosis/efectos de los fármacos , Mycobacterium tuberculosis/ultraestructura , Concentración Osmolar , Péptidos/síntesis química , Péptidos/toxicidad , Estructura Secundaria de Proteína , Proteínas Recombinantes/síntesis química , Proteínas Recombinantes/aislamiento & purificación , Subgrupos de Linfocitos T/microbiologíaRESUMEN
Tuberculosis remains one of the most significant diseases of humans and animals. The only currently available vaccine against this disease is a live, attenuated vaccine, bacillus Calmette-Guérin (BCG), which was originally derived from Mycobacterium bovis and despite its variable efficacy is the most widely administered vaccine in the world. With the advent of the human immunodeficiency virus-AIDS pandemic concern has been raised over the safety of BCG. Moreover, since BCG sensitizes vaccinated individuals to the tuberculin test, vaccination with BCG prevents diagnosis of infection in vaccinated individuals. Recently, auxotrophic strains of BCG have been generated by insertional mutagenesis which have been shown to be safer than the parent BCG strain following administration to mice with severe combined immunodeficiency disease. These strains have also been shown to give comparable protection against intravenous and intratracheal challenge of BALB/c mice with M. tuberculosis relative to conventional BCG. Here we report that one of these mutants, a leucine auxotroph of BCG, conferred significant protection of the lungs and spleens of guinea pigs infected with M. bovis and protection of the spleens of guinea pigs infected with M. tuberculosis in the absence of a cutaneous hypersensitivity reaction to tuberculin. Therefore, protective immunity to tuberculosis may, at least in part, be achieved without sensitization to the tuberculin skin test. These results indicate that it may be possible to develop a new generation of vaccines based on BCG that are protective, are safe for use in the immunocompromised, and do not preclude the use of the tuberculin skin test in both humans and animals.
Asunto(s)
Vacuna BCG/inmunología , Prueba de Tuberculina , Tuberculosis Pulmonar/prevención & control , Animales , Bovinos , Cobayas , Hipersensibilidad Tardía/etiología , Leucina/metabolismo , Mutagénesis InsercionalRESUMEN
To understand the mechanism of T cell help for IgG production in systemic lupus erythematosus (SLE) we investigated the response of CD4- and CD8-negative (double-negative (DN)) T cells because 1) DN T cells are present at unusually high frequency in patients with SLE and can induce pathogenic autoantibodies; 2) the DN T cell repertoire includes cells restricted by CD1 Ag-presenting molecules; and 3) CD1c is expressed on a population of circulating B cells. We derived DN T cell lines from SLE patients and healthy individuals. In the presence of CD1(+) APCs, DN T cell lines from SLE patients produced both IL-4 and IFN-gamma, whereas DN T cells from healthy donors produced IFN-gamma, but no IL-4. In general, cells from patients with highly active disease produced high levels of IFN-gamma; cells from those with little activity produced high IL-4. Coculture of CD1c-directly reactive T cells from healthy donors with CD1c(+) B cells elicited IgM Abs, but little or no IgG. In contrast, CD1c-directly reactive T cells from SLE patients induced isotype switching, with a striking increase in IgG production. Neutralizing Abs to CD1c inhibited the ability of DN T cells to induce IgG production from CD1c(+) B cells, further indicating that CD1c mediated the T and B cell interaction. IgG production was also inhibited by neutralizing Abs to IL-4, correlating with the cytokine pattern of DN T cells derived from these patients. The data suggest that CD1c-restricted T cells from SLE patients can provide help to CD1c(+) B cells for IgG production and could therefore promote pathogenic autoantibody responses in SLE.
Asunto(s)
Antígenos CD1/inmunología , Inmunoglobulina G/biosíntesis , Lupus Eritematoso Sistémico/inmunología , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Linfocitos T Colaboradores-Inductores/inmunología , Adolescente , Adulto , Anciano , Presentación de Antígeno , Antígenos CD1/metabolismo , Linfocitos B/inmunología , Linfocitos B/metabolismo , Línea Celular , Células Cultivadas , Células Dendríticas/inmunología , Femenino , Sangre Fetal/citología , Sangre Fetal/inmunología , Sangre Fetal/metabolismo , Humanos , Interleucina-4/biosíntesis , Lupus Eritematoso Sistémico/metabolismo , Cooperación Linfocítica , Masculino , Persona de Mediana Edad , Isoformas de Proteínas/inmunología , Isoformas de Proteínas/metabolismoRESUMEN
Studies of mouse models of tuberculosis (TB) infection have indicated a central role for MHC class I-restricted CD8+ T cells in protective immunity. To define antigens and epitopes of Mycobacterium tuberculosis (MTB) proteins that are presented by infected cells to CD8+ T cells, we screened 40 MTB proteins for HLA class I A*0201-binding motifs. Peptides that bound with high affinity to purified HLA molecules were subsequently analyzed for recognition by CD8+ cytotoxic T lymphocytes. We identified three epitopes recognized by CD8+ T cells from patients recovering from TB infection. Those three epitopes were derived from three different antigens: thymidylate synthase (ThyA(30-38)), RNA polymerase beta-subunit (RpoB(127-135)), and a putative phosphate transport system permease protein A-1 (PstA1(75-83)). In addition, CD8+ T cell lines specific for three peptides (ThyA(30-38), PstA1(75-83), and 85B(15-23)) were generated from peripheral blood mononuclear cells of normal HLA-A*0201 donors. These CD8+ T cell lines specifically recognized MTB-infected macrophages, as demonstrated by production of IFN-gamma and lysis of the infected target cells. Finally, CD8+ cytotoxic T lymphocytes reduced the viability of the intracellular MTB, providing evidence that CD8+ T cell recognition of MHC class I-restricted epitopes of these MTB antigens can contribute to effective immunity against the pathogen.
Asunto(s)
Linfocitos T CD8-positivos/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Mycobacterium tuberculosis/inmunología , Tuberculosis/inmunología , Animales , Citotoxicidad Inmunológica , Humanos , Interferón gamma/inmunología , Interferón gamma/metabolismo , Macrófagos/inmunología , Macrófagos/metabolismo , RatonesRESUMEN
In the elemental struggle between pathogenic microbes and the immune system of the host, each strives for a unique advantage and thus each exploits its own unique particularities in pathogenesis and protection. And each presumably selects for the diversity that generally characterizes the wide range of successful host-pathogen interactions.
Asunto(s)
Bacterias , Antibacterianos/uso terapéutico , Bacterias/genética , Bacterias/inmunología , Bacterias/patogenicidad , Infecciones Bacterianas/tratamiento farmacológico , Infecciones Bacterianas/microbiología , Evaluación Preclínica de MedicamentosRESUMEN
Over 2 billion people are estimated to be infected with virulent Mycobacterium tuberculosis, yet fewer than 10% progress to clinical tuberculosis within their lifetime. Twin studies and variations in the outcome of tuberculosis infection after exposure to similar environmental risks suggest genetic heterogeneity among individuals in their susceptibility to disease. In a mouse model of tuberculosis, we have established that resistance and susceptibility to virulent M. tuberculosis is a complex genetic trait. A new locus with a major effect on tuberculosis susceptibility, designated sst1 (susceptibility to tuberculosis 1), was mapped to a 9-centimorgan (cM) interval on mouse chromosome 1. It is located 10-19 cM distal to a previously identified gene, Nramp1, that controls the innate resistance of mice to the attenuated bacillus Calmette-Guérin vaccine strain. The phenotypic expression of the newly identified locus is distinct from that of Nramp1 in that sst1 controls progression of tuberculosis infection in a lung-specific manner. Mice segregating at the sst1 locus exhibit marked differences in the growth rates of virulent tubercle bacilli in the lungs. Lung lesions in congenic sst1-susceptible mice are characterized by extensive necrosis and unrestricted extracellular multiplication of virulent mycobacteria, whereas sst1-resistant mice develop interstitial granulomas and effectively control multiplication of the bacilli. The resistant allele of sst1, although powerful in controlling infection, is not sufficient to confer full protection against virulent M. tuberculosis, indicating that other genes located outside of the sst1 locus are likely also to be important for controlling tuberculosis infection.
Asunto(s)
Mycobacterium tuberculosis/patogenicidad , Tuberculosis/genética , Animales , Mapeo Cromosómico , Cruzamientos Genéticos , Modelos Animales de Enfermedad , Predisposición Genética a la Enfermedad/genética , Inmunidad Innata/genética , Pulmón/inmunología , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Neumonía/inmunología , Tuberculosis/microbiología , VirulenciaRESUMEN
Attenuated mutants of Mycobacterium tuberculosis represent potential vaccine candidates for the prevention of tuberculosis. It is known that auxotrophs of a variety of bacteria are attenuated in vivo and yet provide protection against challenge with wild-type organisms. A leucine auxotroph of M. tuberculosis was created by allelic exchange, replacing wild-type leuD (Rv2987c), encoding isopropyl malate isomerase, with a mutant copy of the gene in which 359 bp had been deleted, creating a strain requiring exogenous leucine supplementation for growth in vitro. The frequency of reversion to prototrophy was <10(-11). In contrast to wild-type M. tuberculosis, the DeltaleuD mutant was unable to replicate in macrophages in vitro. Its attenuation in vivo and safety as a vaccine were established by the fact that it caused no deaths in immunodeficient SCID mice. Complementation of the mutant with wild-type leuD abolished the requirement for leucine supplementation and restored the ability of the strain to grow both in macrophages and in SCID mice, thus confirming that the attenuated phenotype was due to the DeltaleuD mutation. As a test of the vaccine potential of the leucine auxotroph, immunocompetent BALB/c mice, susceptible to fatal infection with wild-type M. tuberculosis, were immunized with the DeltaleuD mutant and subsequently challenged with virulent M. tuberculosis by both the intravenous and aerosol routes. A comparison group of mice was immunized with conventional Mycobacterium bovis BCG vaccine. Whereas all unvaccinated mice succumbed to intravenous infection within 15 weeks, mice immunized with either BCG or the DeltaleuD mutant of M. tuberculosis exhibited enhanced and statistically equivalent survival curves. However, the leuD auxotroph was less effective than live BCG in reducing organ burdens and tissue pathology of mice challenged by either route. We conclude that attenuation and protection against M. tuberculosis challenge can be achieved with a leucine auxotroph and suggest that to induce optimal protection, attenuated strains of M. tuberculosis should persist long enough and be sufficiently metabolically active to synthesize relevant antigens for an extended period of time.
Asunto(s)
Hidroliasas , Isomerasas/inmunología , Leucina/inmunología , Mycobacterium tuberculosis/enzimología , Animales , Proteínas Bacterianas/genética , Proteínas Bacterianas/inmunología , Células Cultivadas , Líquido Intracelular/microbiología , Isomerasas/genética , Leucina/biosíntesis , Macrófagos/citología , Ratones , Ratones Endogámicos BALB C , Ratones SCID , Mutagénesis , Mycobacterium bovis , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/inmunología , Tuberculosis/prevención & controlRESUMEN
Catalase is widely used as a pharmacological probe to evaluate the role of hydrogen peroxide in antimicrobial activities of phagocytic cells. This report demonstrates that the ability of a commercial preparation of catalase to inhibit concomitantly macrophage antimycobacterial activity and production of reactive nitrogen intermediates can be attributed, at least in part, to the depletion of L-arginine by contaminating arginase. In experimental systems that employ pharmacological probes, the existence of nonspecific effects should be considered in data interpretation.
Asunto(s)
Arginasa/metabolismo , Catalasa/metabolismo , Macrófagos Peritoneales/metabolismo , Óxido Nítrico/biosíntesis , Animales , Células Cultivadas , Citrulina/metabolismo , Interferón gamma/farmacología , Lipopolisacáridos/farmacología , Activación de Macrófagos , Macrófagos Peritoneales/efectos de los fármacos , Ratones , Ratones Endogámicos BALB CRESUMEN
A necessary role for cytotoxic T lymphocytes in protection against Mycobacterium tuberculosis (MTB) has been suggested by studies of the beta2-microglobulin-deficient mouse, which is unable to present antigens through MHC class I and class I-like molecules and invariably succumbs early after infection. To identify the relative contributions of distinct putative MHC class I-dependent cell populations in protection against tuberculosis, we compared a variety of gene-disrupted mouse strains for susceptibility to MTB infection. Among the strains tested, the most susceptible mice, as measured by survival time and bacterial loads, were the beta2-microglobulin(-/-), followed by transporter associated with antigen processing deficient (TAP1(-/-)), CD8alpha(-/-), perforin(-/-), and CD1d(-/-) mice. These findings indicated that (i) CD8(+) T cells contribute to protection against MTB, and their protective activity is only partially dependent on perforin; (ii) beta2-microglobulin-dependent T cell populations distinct from CD8(+) T cells also contribute to anti-MTB immunity; and (iii) protective immune mechanisms are predominantly TAP-dependent, although TAP-independent mechanisms also contribute to protection. Because CD1d-deficient animals were fully resistant to MTB, other TAP-independent mechanisms must contribute to protection. We suggest here that both classical and nonclassical MHC class I-restricted T cells, distinct from CD1d-restricted cells, may be involved in protective immune responses against tuberculosis.
Asunto(s)
Antígenos de Histocompatibilidad Clase I/inmunología , Tuberculosis/prevención & control , Animales , Linfocitos T CD8-positivos/inmunología , Pulmón/patología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Tuberculosis/inmunología , Tuberculosis/veterinariaRESUMEN
Cell-mediated immunity is critical for host resistance to tuberculosis. T lymphocytes recognizing antigens presented by the major histocompatibility complex (MHC) class I and class II molecules have been found to be necessary for control of mycobacterial infection. Mice genetically deficient in the generation of MHC class I and class Ia responses are susceptible to mycobacterial infection. Although soluble protein antigens are generally presented by macrophages to T cells through MHC class II molecules, macrophages infected with Mycobacterium tuberculosis or bacille Calmette-Guerin have been shown to facilitate presentation of ovalbumin through the MHC class I presentation pathway via a TAP-dependent mechanism. How mycobacteria, thought to reside within membrane-bound vacuoles, facilitate communication with the cytoplasm and enable MHC class I presentation presents a paradox. By using confocal microscopy to study the localization of fluorescent-tagged dextrans of varying size microinjected intracytoplasmically into macrophages infected with bacille Calmette-Guerin expressing the green fluorescent protein, molecules as large as 70 kilodaltons were shown to gain access to the mycobacterial phagosome. Possible biological consequences of the permeabilization of vacuolar membranes by mycobacteria would be pathogen access to host cell nutrients within the cytoplasm, perhaps contributing to bacterial pathogenesis, and access of microbial antigens to the MHC class I presentation pathway, contributing to host protective immune responses.
Asunto(s)
Toxinas Bacterianas , Células de la Médula Ósea/microbiología , Macrófagos/microbiología , Mycobacterium/patogenicidad , Fagosomas/fisiología , Animales , Presentación de Antígeno , Biomarcadores , Compartimento Celular , Línea Celular , Citoplasma/metabolismo , Proteínas de Choque Térmico/metabolismo , Proteínas Hemolisinas , Antígenos de Histocompatibilidad Clase I , Listeria monocytogenes/patogenicidad , Ratones , Ratones Endogámicos C57BL , Microinyecciones , Peso Molecular , Mycobacterium/inmunología , Mycobacterium bovis/inmunología , Mycobacterium bovis/patogenicidad , Mycobacterium smegmatis/inmunología , Mycobacterium smegmatis/patogenicidad , Mycobacterium tuberculosis/inmunología , Mycobacterium tuberculosis/patogenicidad , PermeabilidadRESUMEN
Public health deals with the health and well-being of the population as a whole and its achievements over the past century, especially in the richer countries, have been truly impressive. What direction should public health take in the future?